Views & Analysis AMR: How pharma is leading the charge against superbugs GPs being sent warning letters and the World Health Organization’s World Vaccinations Week have brought the spectre of antimicrobial resistance (AMR) back into the headlines of late.
Partner Content Partner Content Superbugs & Superdrugs USA Conference returns to New Jer... Superbugs & Superdrugs USA Conference, Nov 2018
Views & Analysis Medtech is key in fight against AMR Paul Chapman examines the challenge of antimicrobial resistance (AMR) and how it could be beaten.
Partner Content Partner Content AMR research, funding and incentives – updates at SMi event ... SMi reports: Antimicrobial resistance was predicted by Alexander Fleming in his Nobel lecture (1945).
News UK and Russian experts tackle superbugs The AMR Centre is to collaborate with Russia's Skolkovo Foundation
Partner Content Partner Content “SPARKing" New Antibiotic Drug Discovery “SPARKing" New Antibiotic Drug Discovery
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.